Investigator Site 1
Investigator Site 1
Chicago, Illinois, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis | focal segmental glomerulosclerosis | Recruiting | Phase 2 / Phase 3 | 2026-09-02 | NCT07213960 |